Dear Colleagues,
The 2024 Duke Industry Statistics Symposium (DISS2024) will be held on April 3-5, 2024 in Durham, North Carolina. With the theme Statistical Innovation for Next-Generation Pharmaceutical Development, the symposium will explore the forefront of statistical innovation in next-generation clinical research for pharmaceutical products. While the event is only about three weeks away, it is not too late to register for the event. Attached is a flyer for the symposium to share with your colleagues and friends. For updated information about the program schedule, including short courses, speakers, talk abstracts, poster submission, and registration, please visit https://sites.duke.edu/diss
The DISS2024 offers the following programs:
· Two keynote presentations by Dr. Peter Stein, the Director of FDA CDER's Office of New Drugs, on "Changes in the Drug Development and Regulatory Landscape: Evolutions and Revolutions" and Dr. Venkat Sethuraman, the Sr Vice President of Global Biometrics and Data Sciences of Bristol Myers Squibb, on "The Power of AI, Data Sciences, and Technology in Drug Development"
· Five short courses about AI/ML for Clinical Trials and Humanized AI for Future Healthcare, Dose Optimization, Pragmatic Benefit/Risk Evaluation, Adaptive Platform Trials, and Evaluation of Surrogate Endpoints in Oncology
· Seventeen parallel sessions with invited speakers from industry, regulatory agencies, and academics with various topics about the forefront of statistical innovation in next-generation clinical research for pharmaceutical products
Registration fees are significantly reduced for all undergraduate and graduate students with majors in statistics, biostatistics, and data sciences with viable credentials. If you have further questions about the symposium, please contact Judy Adkins at judy.adkins@duke.edu.
The Duke-Industry Statistics Symposium (DISS) is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and several industry and non-profit partners. The first symposium was established in 2013 to discuss challenging issues and recent advances related to the clinical development of drugs, biologics, and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.
Sincerely yours,
The Organizing Committee of DISS2024
------------------------------
Xiaofei Wang
Duke University Medical Center
------------------------------